Metrics as of 10/15/2026, 11:28 AM (Berlin time), refresh in progress.
Citius Pharmaceuticals Stock
Citius Pharmaceuticals, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Leonard L. Mazur
- Employees
- 23
- Market cap
- $13 M
- IPO
- 02/10/2014
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal…
Citius Pharmaceuticals stock: price history
1D
-1.1%
1W
-5.9%
1M
-17.9%
6M
-46.2%
YTD
-40.8%
1Y
-66.9%
2Y
-95.1%
5Y
-99.1%
10Y
-99.8%
Next earnings date
Next earnings date
17/12/2026 (in 61 days)
Volatility around earnings
~13% stronger price swings than usual
Ask the agents about Citius Pharmaceuticals
Analyst assessment of Citius Pharmaceuticals
0
STRONG BUY
5
BUY
1
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 11/03/2026
Citius Pharmaceuticals stock metrics
P/E
-0.22
P/B
0.18
EV/EBITDA
-0.05
RETURN ON EQUITY
-13.3%
NET MARGIN
-593.3%
DEBT/EQUITY
0.11
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.2%
FLOAT SHARES
26,959,796
AVG. DAILY VOLUME (30D)
190,765
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Citius Pharmaceuticals stock
What does Citius Pharmaceuticals do?
Citius Pharmaceuticals, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Leonard L. Mazur, the company employs around 23 people.
The IPO was on 02/10/2014; the stock trades on NASDAQ under the ticker CTXR.
What do analysts say about Citius Pharmaceuticals stock?
6 analysts rate the stock, the consensus is Buy (as of 11/03/2026).
This is an external assessment, not a statement by Market Jury.
When does Citius Pharmaceuticals report next?
The next earnings date is 17/12/2026.
Around past earnings, price swings were roughly 13% stronger than usual.
Does Citius Pharmaceuticals pay a dividend?
No, Citius Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to Citius Pharmaceuticals?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Citius Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Citius Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.